Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium - Scorecard - MDSpire

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

  • April 6, 2026

  • 3 min

Share

Clinical Scorecard: 2026 Brain & Spine Symposium

At a Glance

CategoryDetail
ConditionNeuroscience and related disorders
Key MechanismsAdvances in brain and spine surgery, interventional pain management, and neurorehabilitation
Target PopulationPhysicians, researchers, and clinical experts in neuroscience
Care SettingIn-person symposium at Marcus Neuroscience Institute, Baptist Health South Florida

Key Highlights

  • Two-day event featuring lectures and interactive discussions
  • Focus on evidence-based practices in various neuroscience fields
  • Multidisciplinary care and complex case management emphasized
  • Emerging research shaping future of neuroscience care
  • Networking opportunities with leading experts in the field

Guideline-Based Recommendations

Diagnosis

  • Utilize latest diagnostic techniques in neuroscience

Management

  • Implement evidence-based treatment innovations

Monitoring & Follow-up

  • Regularly assess patient outcomes in neuromuscular and cognitive disorders

Risks

  • Consider potential complications in minimally invasive and robotic spine techniques

Patient & Prescribing Data

Patients with neurological disorders and conditions requiring neurosurgical intervention

Focus on personalized treatment options based on latest research and expert recommendations

Clinical Best Practices

  • Engage in multidisciplinary collaboration for complex cases
  • Stay updated on advancements in neurorehabilitation and pain management
  • Adopt minimally invasive techniques where applicable

Related Resources & Content

Original Source(s)

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

  • April 6, 2026

Related Content

Stroke Audit Finds Long CT-to-CTA Times

A regional UK audit found wide variation in imaging intervals among patients referred for mechanical thrombectomy and identified potentially modifiable barriers to timely vascular imaging.

Language Processing Persists Under Anesthesia

Intraoperative recordings suggested preserved processing of speech and auditory context during unconsciousness.

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.